Trial intelligence / Profile preview

VR Hypnosis vs Drug Sedation for Venous Access Device Implantation

NCT05815056Completed

Sponsor
CHR de Huy
Start
Mar 2022
Primary completion
Aug 2022
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by CHR de Huy. Primary endpoint: Successful implantation of a veinous access device. Started Mar 2022; status: completed.

Beyond the preview

Go deeper on NCT05815056.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05815056.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call